Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Radiation Injuries × Carboplatin × Clear all

Phase

Phase 3 3 Phase 2 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 68 Ovarian Neoplasms 42 Lung Neoplasms 23 Breast Neoplasms 23 Fallopian Tube Neoplasms 21 Small Cell Lung Carcinoma 14 Neoplasms 14 Carcinoma, Ovarian Epithelial 14 Triple Negative Breast Neoplasms 13 Glioblastoma 12 Squamous Cell Carcinoma of Head and Neck 10 Recurrence 10 Endometrial Neoplasms 10 Head and Neck Neoplasms 9 Colorectal Neoplasms 9 Uterine Cervical Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 8 Hodgkin Disease 8 Brain Neoplasms 8 Stomach Neoplasms 7 Neoplasm Metastasis 6 Glioma 6 Esophageal Neoplasms 6 Central Nervous System Neoplasms 6 Adenocarcinoma of Lung 6 Lymphoma, Mantle-Cell 5 Lymphoma 5 Gliosarcoma 5 Esophageal Squamous Cell Carcinoma 5 Astrocytoma 5

Interventions

Radiotherapy 4 Paclitaxel 3 Cisplatin 3 Amifostine 3 sodium propionate 1 ethanethiol 1 Topotecan 1 Radiation Protection 1 Pentetic Acid 1 Filgrastim 1 Fatty Acids, Volatile 1 Etoposide 1 Daclizumab 1 Carboplatin 1 Butyric Acid 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00618917 2021-11-12

MnSOD

University of Pittsburgh

Phase 1/2 Terminated

18 enrolled 12 charts

Lung Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡